Filed: 5/15/2026ACC: 0001420506-26-001072
📋 What this filing means
PARKMAN HEALTHCARE PARTNERS LLC filed this quarterly 13F‑HR report disclosing 90 equity positions with a total reported market value of $969.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
90
Positions
$969.64M
Total AUM (reported)
38.26M
Total Shares
Allocation by class
COM$821.63M84.7%
COM NEW$57.03M5.9%
SHS$29.38M3.0%
ORD SHARES$20.02M2.1%
SPONSORED ADS$14.25M1.5%
ORD SHS CL A$12.48M1.3%
COM CL A$5.46M0.6%
Portfolio Concentration
Top 3$131.13M13.5%
4–10$205.04M21.1%
11–25$273.16M28.2%
Rest$360.32M37.2%
Top 3 weight
13.5%
Top 10 weight
34.7%
Voting Authority Distribution
Total shares with voting rights: 38.26M
Sole
Full voting authority
38.26M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole90
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings90
Rows:
STRYKER CORPORATION
SOLEShares154.77K
TypeSH
Market value$50.86M
5.24%
Sole
154.77K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares689.82K
TypeSH
Market value$43.32M
4.47%
Sole
689.82K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.84M
TypeSH
Market value$36.95M
3.81%
Sole
1.84M
Shared
0.00
None
0.00
INSULET CORP
SOLEShares156.56K
TypeSH
Market value$32.85M
3.39%
Sole
156.56K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares34.62K
TypeSH
Market value$31.84M
3.28%
Sole
34.62K
Shared
0.00
None
0.00
PTC THERAPEUTICS INC
SOLEShares431.36K
TypeSH
Market value$29.39M
3.03%
Sole
431.36K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares497.04K
TypeSH
Market value$28.90M
2.98%
Sole
497.04K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares448.77K
TypeSH
Market value$28.16M
2.90%
Sole
448.77K
Shared
0.00
None
0.00
CVS HEALTH CORP
SOLEShares387.31K
TypeSH
Market value$27.82M
2.87%
Sole
387.31K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares1.21M
TypeSH
Market value$26.08M
2.69%
Sole
1.21M
Shared
0.00
None
0.00
LIVANOVA PLC
SOLEShares403.96K
TypeSH
Market value$25.68M
2.65%
Sole
403.96K
Shared
0.00
None
0.00
ZIMMER BIOMET HOLDINGS INC
SOLEShares269.56K
TypeSH
Market value$24.37M
2.51%
Sole
269.56K
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares800.04K
TypeSH
Market value$23.88M
2.46%
Sole
800.04K
Shared
0.00
None
0.00
ANI PHARMACEUTICALS INC
SOLEShares280.57K
TypeSH
Market value$21.58M
2.23%
Sole
280.57K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares901.51K
TypeSH
Market value$21.06M
2.17%
Sole
901.51K
Shared
0.00
None
0.00
QIAGEN NV
SOLEShares500K
TypeSH
Market value$20.02M
2.06%
Sole
500K
Shared
0.00
None
0.00
ENVISTA HOLDINGS CORPORATION
SOLEShares711.69K
TypeSH
Market value$18.06M
1.86%
Sole
711.69K
Shared
0.00
None
0.00
EYEPOINT INC
SOLEShares1.35M
TypeSH
Market value$17.46M
1.80%
Sole
1.35M
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares75K
TypeSH
Market value$16.31M
1.68%
Sole
75K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares1.71M
TypeSH
Market value$16.26M
1.68%
Sole
1.71M
Shared
0.00
None
0.00
IQVIA HLDGS INC
SOLEShares86.70K
TypeSH
Market value$14.79M
1.52%
Sole
86.70K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares403.52K
TypeSH
Market value$13.65M
1.41%
Sole
403.52K
Shared
0.00
None
0.00
ILLUMINA INC
SOLEShares110.37K
TypeSH
Market value$13.60M
1.40%
Sole
110.37K
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
SOLEShares167.16K
TypeSH
Market value$13.39M
1.38%
Sole
167.16K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares99.07K
TypeSH
Market value$13.05M
1.35%
Sole
99.07K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
STRYKER CORPORATIONSOLE | COM | 154.77K | SH | $50.86M 5.24% | 154.77K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 689.82K | SH | $43.32M 4.47% | 689.82K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.84M | SH | $36.95M 3.81% | 1.84M | 0.00 | 0.00 |
INSULET CORPSOLE | COM | 156.56K | SH | $32.85M 3.39% | 156.56K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 34.62K | SH | $31.84M 3.28% | 34.62K | 0.00 | 0.00 |
PTC THERAPEUTICS INCSOLE | COM | 431.36K | SH | $29.39M 3.03% | 431.36K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 497.04K | SH | $28.90M 2.98% | 497.04K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 448.77K | SH | $28.16M 2.90% | 448.77K | 0.00 | 0.00 |
CVS HEALTH CORPSOLE | COM | 387.31K | SH | $27.82M 2.87% | 387.31K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 1.21M | SH | $26.08M 2.69% | 1.21M | 0.00 | 0.00 |
LIVANOVA PLCSOLE | SHS | 403.96K | SH | $25.68M 2.65% | 403.96K | 0.00 | 0.00 |
ZIMMER BIOMET HOLDINGS INCSOLE | COM | 269.56K | SH | $24.37M 2.51% | 269.56K | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 800.04K | SH | $23.88M 2.46% | 800.04K | 0.00 | 0.00 |
ANI PHARMACEUTICALS INCSOLE | COM | 280.57K | SH | $21.58M 2.23% | 280.57K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 901.51K | SH | $21.06M 2.17% | 901.51K | 0.00 | 0.00 |
QIAGEN NVSOLE | ORD SHARES | 500K | SH | $20.02M 2.06% | 500K | 0.00 | 0.00 |
ENVISTA HOLDINGS CORPORATIONSOLE | COM | 711.69K | SH | $18.06M 1.86% | 711.69K | 0.00 | 0.00 |
EYEPOINT INCSOLE | COM NEW | 1.35M | SH | $17.46M 1.80% | 1.35M | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 75K | SH | $16.31M 1.68% | 75K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 1.71M | SH | $16.26M 1.68% | 1.71M | 0.00 | 0.00 |
IQVIA HLDGS INCSOLE | COM | 86.70K | SH | $14.79M 1.52% | 86.70K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 403.52K | SH | $13.65M 1.41% | 403.52K | 0.00 | 0.00 |
ILLUMINA INCSOLE | COM | 110.37K | SH | $13.60M 1.40% | 110.37K | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPSOLE | COM | 167.16K | SH | $13.39M 1.38% | 167.16K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 99.07K | SH | $13.05M 1.35% | 99.07K | 0.00 | 0.00 |
Page 1 of 4